Yayın:
Reversal of haemorrhagic shock in rats by tetrahydroaminoacridine

dc.contributor.buuauthorSavcı, Vahide
dc.contributor.buuauthorÇavun, Sinan
dc.contributor.buuauthorGürun, Mine Sibel
dc.contributor.buuauthorUlus, İsmail Hakkı
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentFarmakoloji ve Klinik Darmakoloji Ana Bilim Dalı
dc.contributor.researcheridAAG-8716-2019
dc.contributor.researcheridAAC-9702-2019
dc.contributor.researcheridD-5340-2015
dc.contributor.scopusid6603687024
dc.contributor.scopusid6507468595
dc.contributor.scopusid55664349700
dc.contributor.scopusid7004271086
dc.date.accessioned2022-01-21T07:18:47Z
dc.date.available2022-01-21T07:18:47Z
dc.date.issued2001
dc.description.abstractThe cardiovascular effects of tetrahydroaminoacridine (tacrine; THA) were investigated in haemorrhaged rats. Intracerebroventricular (i.c.v.) injection of THA (10, 25 and 50 mug) restored blood pressure in a dose- and time-dependent manner. Atropine (10 mug, i.c.v.), a muscarinic receptor antagonist, attenuated the presser response to THA (25 mug, i.c.v.), while mecamylamine (50 mug, i.c.v.), a nicotinic receptor antagonist, caused only a slight blockade in the presser effect of THA. Simultaneous pretreatment with atropine and mecamylamine almost abolished the blood pressure effect of i.c.v. THA (25 mug). Haemorrhage increased plasma levels of adrenaline, noradrenaline, vasopressin and plasma renin activity. THA (25 mug, i.c.v.) administration caused additional increases in vasopressin and adrenaline levels but not of renin activity and noradrenaline levels. The reversal of hypotension by THA was greatly attenuated by administration of either prazosin, an al-adrenoceptor antagonist (0.5 mg/kg, i.v.) or by the vasopressin V-1 receptor antagonist [beta -mercapto-beta,beta -cyclopenta-methylenepropionyl(1), O-Me-Tyr(2)-Arg(8)]-vasopressin (10 mug/kg, i.v.). Pretreatment of rats with both prazosin and the vasopressin antagonist simultaneously completely inhibited the presser response. Intravenous administration of THA (1, 1.5 and 3 mg/kg) also reversed hypotension in rats. Atropine (10 mug, i.c.v.) greatly attenuated the presser response to THA (1.5 mg/kg, i.v.), while mecamylamine (50 mug, i.c.v.) failed to change the presser effect of THA. In anaesthetised haemorrhaged rats, THA (1.5 mg/kg, i.v.) increased blood pressure and survival time of the animals. These results show that centrally and peripherally injected THA reverses haemorrhagic hypotension and increases survival time in rats. Activation of central muscarinic and nicotinic receptors is involved in the presser response to i.c.v. THA. The presser effect of i.v. THA is solely mediated by central muscarinic receptors. Moreover, the increase in plasma adrenaline and vasopressin levels appears to be involved in the presser effect of THA.
dc.identifier.citationSavcı, V. vd. (2001). "Reversal of haemorrhagic shock in rats by tetrahydroaminoacridine". Pharmacology, 62(1), 36-44.
dc.identifier.doi10.1159/000056070
dc.identifier.endpage44
dc.identifier.issn0031-7012
dc.identifier.issue1
dc.identifier.pubmed11150921
dc.identifier.scopus2-s2.0-0035165180
dc.identifier.startpage36
dc.identifier.urihttps://doi.org/10.1159/000056070
dc.identifier.urihttps://www.karger.com/Article/Abstract/56070
dc.identifier.urihttp://hdl.handle.net/11452/24204
dc.identifier.volume62
dc.identifier.wos000166591900007
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherKarger
dc.relation.journalPharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHaemorrhage
dc.subjectAdrenaline
dc.subjectBlood pressure
dc.subjectCholinergic receptor mechanisms
dc.subjectCholinesterase inhibitor
dc.subjectHypotension
dc.subjectTetrahydroaminoacridine
dc.subjectVasopressin
dc.subjectAcetylcholine-release
dc.subjectNervous-system
dc.subjectBlood-pressure
dc.subjectTacrine
dc.subjectCholine
dc.subjectBrain
dc.subjectPhysostigmine
dc.subjectInvivo
dc.subjectM(2)
dc.subject.emtreePrazosin
dc.subject.emtreeAdrenalin
dc.subject.emtreeAtropine
dc.subject.emtreeMecamylamine
dc.subject.emtreeMuscarinic receptor
dc.subject.emtreeNicotinic receptor
dc.subject.emtreeNoradrenalin
dc.subject.emtreeTacrine
dc.subject.emtreeNoradrenalin blood level
dc.subject.emtreeVasopressin
dc.subject.emtreeVasopressin receptor antagonist
dc.subject.emtreeAdrenalin blood level
dc.subject.emtreeAnimal experiment
dc.subject.emtreePressor response
dc.subject.emtreeAnimal model
dc.subject.emtreeArticle
dc.subject.emtreeFemale hypotension
dc.subject.emtreeBlood pressure regulation
dc.subject.emtreeCardiovascular effect
dc.subject.emtreeControlled study
dc.subject.emtreeDose time effect relation
dc.subject.emtreeHemorrhagic shock
dc.subject.emtreeMale
dc.subject.emtreeNonhuman
dc.subject.emtreePlasma renin activity
dc.subject.emtreePriority journal
dc.subject.emtreeSurvival
dc.subject.emtreeVasopressin blood level
dc.subject.meshAdrenergic alpha-antagonists
dc.subject.meshAnesthetics, intravenous
dc.subject.meshAnimals
dc.subject.meshSurvival analysis
dc.subject.meshCardiovascular agents
dc.subject.meshCholinesterase inhibitors
dc.subject.meshEpinephrine
dc.subject.meshAtropine
dc.subject.meshBlood pressure
dc.subject.meshDose-response relationship, drug
dc.subject.meshFemale
dc.subject.meshHypotension
dc.subject.meshInjections, intravenous
dc.subject.meshInjections, intraventricular
dc.subject.meshMale
dc.subject.meshMecamylamine
dc.subject.meshNorepinephrine
dc.subject.meshPrazosin
dc.subject.meshRats
dc.subject.meshRats, wistar
dc.subject.meshReceptors, vasopressin
dc.subject.meshRenin
dc.subject.meshShock, hemorrhagic
dc.subject.meshTacrine
dc.subject.meshTime factors
dc.subject.meshUrethane
dc.subject.meshVasopressins
dc.subject.scopusCiticoline; Neuroprotective Agents; Glycerylphosphorylcholine
dc.subject.wosPharmacology & pharmacy
dc.titleReversal of haemorrhagic shock in rats by tetrahydroaminoacridine
dc.typeArticle
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Farmakoloji ve Klinik Darmakoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama